Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:19 AM
Ignite Modification Date:
2025-12-25 @ 3:19 AM
NCT ID:
NCT03058705
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of bladder mass on office cystoscopy suspicious for malignancy, either newly diagnosed or a recurrent tumor.
* Planned transurethral resection of bladder tumor in the operating room.
* Ability to give informed consent.
* Willing to spend time for the study
* Men or women (age 18 or older)
* Any racial or ethnic origin
Exclusion Criteria:
* Pregnancy
* Nursing mother
* Diagnosis of porphyria
* Gross hematuria
* BCG immunotherapy or intravesical chemotherapy within the past 90 days
* Known hypersensitivity to hexaminolevulinate or any derivative of aminolevulinic acid
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03058705
Study Brief:
Protocol Section:
NCT03058705